로딩 중…
지수 로딩 중…
Twist Bioscience Corporation
TWST· NASDAQ· Health Care· Health Care Equipment & Services
$101.06+10.39%
2026-08-03
Financials
Valuation Metrics
Twist Bioscience Corporation's Market Cap is $6.29B. At end of 2025 it was $1.94B. Ranked #1296 of 3,111 in US market (top 42%), #435 of 1,445 on NASDAQ (top 30%), #80 of 206 in Health Care Equipment & Services (top 39%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $6.29B | US#1,296/3,111 Sec#80/206 |
| Revenue | $409M | US#2,444/3,111 Sec#152/206 |
| Net Income | $-81M | US—/3,111 Sec—/206 |
| Total Assets | $676M | US#2,630/3,111 Sec#146/206 |
| Net Assets | $455M | US#2,326/3,111 Sec#121/206 |
| Value | ||
| P/B | 13.83x | US#2,695/3,111 Sec#180/206 |
| P/S | 15.37x | US#2,749/3,111 Sec#195/206 |
| FCF Yield | -1.51% | US—/3,111 Sec—/206 |
| Profitability | ||
| ROE | -17.86% | US#2,507/3,111 Sec#150/206 |
| ROA | -12.02% | US#2,687/3,111 Sec#158/206 |
| Op. Margin | -33.90% | US#2,747/3,111 Sec#177/206 |
| Revenue Growth | 19.31% | US#783/3,111 Sec#49/206 |
| Financial Health | ||
| Debt Ratio | 48.59% | US#551/3,111 Sec#65/206 |
| Total Debt | $96M | US#2,429/3,111 Sec#139/206 |
| FCF | $-95M | US#2,585/3,111 Sec#190/206 |
| Cash | $123M | US#2,094/3,111 Sec#133/206 |
| Current Ratio | 2.70x | US#917/3,111 Sec#96/206 |
| Performance | ||
| 1Y Return | 200.06% | US#125/3,111 Sec#10/206 |
| 1M Return | 1.83% | US#2,517/3,111 Sec#166/206 |
| From 52W High | -4.18% | US#1,227/3,111 Sec#81/206 |
| 1Y MDD | -38.24% | US#1,866/3,111 Sec#96/206 |
| Trading | ||
| Volume | 2,905,890 shares | US#1,079/3,111 Sec#65/206 |
| Trading Value | $275M | US#726/3,111 Sec#55/206 |
| Per Share | ||
| EPS | $-1.25 | US—/3,111 Sec—/206 |
| BPS | $7.47 | US#1,995/3,111 Sec#117/206 |